Cell Source, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Cell Source, Inc. (CLCS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 2.21 million shares for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2015-11-16
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2015-09-30 was 1.04M shares.
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2015-06-30 was 670.00K shares.
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2015-03-31 was 500.00K shares.
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2014-12-31 was 0.00 shares.
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2014 was 6.09M shares, a 116.56% increase from fiscal 2013.
- Cell Source, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2013 was 2.81M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2015-09-30 | 1.04M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | 1.72M shares derived: sum of 2 quarters · filed 2015-11-16 | 2.21M shares 10-Q · filed 2015-11-16 | 2.21M shares derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-06-30 | 670.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 1.17M shares 10-Q · filed 2015-08-11 | 1.17M shares derived: sum of 3 quarters · filed 2015-08-11 | 1.17M shares derived: sum of 4 quarters · filed 2015-08-11 |
| 2015-03-31 | 500.00K shares 10-Q · filed 2015-05-13 | 500.00K shares derived: sum of 2 quarters · filed 2015-05-13 | 500.00K shares derived: sum of 3 quarters · filed 2015-05-13 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-13 | 6.09M shares 10-K · filed 2015-03-13 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | 6.09M shares 10-Q · filed 2014-11-14 | ||
| 2014-06-30 | 6.09M shares 10-Q · filed 2014-08-19 | |||
| 2013-12-31 | 2.81M shares 10-K · filed 2015-03-13 |